Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Palliative cancer care - dyspnoea - Background information
How common is dyspnoea in palliative care?

  • Dyspnoea is common in people with cancer in general, but it is more common and severe in people with primary lung cancers [Doyle et al, 2004; Booth and Dudgeon, 2006].
  • The frequency and severity of dyspnoea increase with the progression of disease [Doyle et al, 2004; Booth and Dudgeon, 2006].
  • The prevalence of dyspnoea varies by the site of primary cancer, the stage of the disease, and other factors [Doyle et al, 2004]:
    • In a UK study, three-quarters (216 of 289) of people with non–small-cell lung cancer reported dyspnoea at presentation; 23 (8%) reported severe symptoms, 95 (33%) reported moderate symptoms, and 98 (34%) reported mild symptoms [Muers and Round, 1993].
    • Of 69 people with locally advanced lung cancer who were seen in a community hospital in the US and assessed with the Lung Cancer Symptom Scale, 73% reported dyspnoea [Lutz et al, 2001].
    • A Canadian study of a general cancer outpatient population (n = 923, of whom 4% had lung cancer and 5.4% had lung metastases) found that 46% of people had shortness of breath. However, 6.2% of people had a history of asthma or chronic obstructive pulmonary disease, and 6.2% had a history of cardiac disease. A majority (59.8%) of participants had a history of smoking, and just under a third of people had been exposed to substances that could have caused lung damage [Dudgeon et al, 2001].

© NHS Institute for Innovation and Improvement